Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Lynn E. Spitler
Based on 5 articles published since 2008
||||
Expertise Level
The expertise of Lynn E. Spitler ranks in the
  • Top 2%
  • ... of 107,286 published authors worldwide on Melanoma
  • ... from 2008 through 2019
  • ... based on contributions to 5 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Spitler, Lynn   ·   Spitler, Lynn E
Work Locations
Details
Most likely:    University of Pittsburgh   Contact    
2017
  • *Northern California Melanoma Center, St. Mary's Medical Center, San Francisco §Scott Cruickshank & Associates, Santa Barbara, CA ‡Hillman Cancer Center, The University of Pittsburgh, Pittsburgh, PA †Syrinx Bioanalytics Oy, Turku, Finland. · Pubmed 25286079
Probable:    University of California San Francisco   Contact    
2017
  • *Northern California Melanoma Center, St. Mary's Medical Center, San Francisco §Scott Cruickshank & Associates, Santa Barbara, CA ‡Hillman Cancer Center, The University of Pittsburgh, Pittsburgh, PA †Syrinx Bioanalytics Oy, Turku, Finland. · Pubmed 25286079
Probable:    Miscellaneous institutions in San Francisco      
2015
  • Robert H.I. Andtbacka, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Howard L. Kaufman, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ · Frances Collichio, University of North Carolina Medical Center, Chapel Hill, NC · Thomas Amatruda, Minnesota Oncology, Fridley, MN · Neil Senzer, Mary Crowley Cancer Research Center, Dallas · Merrick Ross, University of Texas MD Anderson Cancer Center, Houston, TX · Jason Chesney, University of Louisville, Louisville, KY · Keith A. Delman, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA · Lynn E. Spitler, Northern California Melanoma Center, San Francisco · Gregory A. Daniels, University of California San Diego Medical Center, Moores Cancer Center, La Jolla · Yining Ye, Bin Yao, Ai Li, Ari Vander Walde, and Jennifer Gansert, Amgen, Thousand Oaks, CA · Igor Puzanov, Vanderbilt University, Nashville, TN · Sanjiv S. Agarwala, St Luke's University Hospital and Health Network, Bethlehem, and Temple University School of Medicine, Philadelphia, PA · Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA · Lee Cranmer, University of Arizona, Tucson, AZ · Brendan Curti, Earle A. Chiles Research Institute, Portland, OR · Karl Lewis, University of Colorado Cancer Center, Aurora, CO · Troy Guthrie, Baptist Cancer Institute, Jacksonville · Jonathan S. Zager, Moffitt Cancer Center, Tampa, FL · Gerald P. Linette, Washington University School of Medicine, St Louis, MO · Kevin Harrington, Institute of Cancer Research, Royal Marsden Hospital, London · Mark R. Middleton, National Institute for Health Research Biomedical Research Centre, Oxford, United Kingdom · Wilson H. Miller Jr, McGill University, Montreal, Quebec, Canada · and Susan Doleman and Robert S. Coffin, Amgen, Woburn, MA. · Pubmed 26014293
  • *Northern California Melanoma Center, St. Mary's Medical Center, San Francisco †The Angeles Clinic and Research Institute, Santa Monica ‡Scott Cruickshank and Associates, Santa Barbara, CA. · Pubmed 25616203
2009
  • Northern California Melanoma Center, Saint Mary's Medical Center, San Francisco, CA 94117-1079, USA. · Pubmed 19483646
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Lynn E. Spitler in 2008-2019 about Melanoma:

  • Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma. 2017
  • Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. 2015
  • Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma. 2015
  • Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma. 2009
  • A phase 1 study of granulocyte macrophage colony-stimulating factor (sargramostim) and escalating doses of thalidomide in patients with high-risk malignant melanoma. 2009
Show List of Full Article Records
Google Searches

Learn more about Lynn E. Spitler using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Pittsburgh
University of California San Francisco
Miscellaneous institutions in San Francisco
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Pittsburgh
2017
  • *Northern California Melanoma Center, St. Mary's Medical Center, San Francisco §Scott Cruickshank & Associates, Santa Barbara, CA ‡Hillman Cancer Center, The University of Pittsburgh, Pittsburgh, PA †Syrinx Bioanalytics Oy, Turku, Finland. · Pubmed 25286079
University of California San Francisco
2017
  • *Northern California Melanoma Center, St. Mary's Medical Center, San Francisco §Scott Cruickshank & Associates, Santa Barbara, CA ‡Hillman Cancer Center, The University of Pittsburgh, Pittsburgh, PA †Syrinx Bioanalytics Oy, Turku, Finland. · Pubmed 25286079
Miscellaneous institutions in San Francisco
2015
  • Robert H.I. Andtbacka, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Howard L. Kaufman, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ · Frances Collichio, University of North Carolina Medical Center, Chapel Hill, NC · Thomas Amatruda, Minnesota Oncology, Fridley, MN · Neil Senzer, Mary Crowley Cancer Research Center, Dallas · Merrick Ross, University of Texas MD Anderson Cancer Center, Houston, TX · Jason Chesney, University of Louisville, Louisville, KY · Keith A. Delman, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA · Lynn E. Spitler, Northern California Melanoma Center, San Francisco · Gregory A. Daniels, University of California San Diego Medical Center, Moores Cancer Center, La Jolla · Yining Ye, Bin Yao, Ai Li, Ari Vander Walde, and Jennifer Gansert, Amgen, Thousand Oaks, CA · Igor Puzanov, Vanderbilt University, Nashville, TN · Sanjiv S. Agarwala, St Luke's University Hospital and Health Network, Bethlehem, and Temple University School of Medicine, Philadelphia, PA · Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA · Lee Cranmer, University of Arizona, Tucson, AZ · Brendan Curti, Earle A. Chiles Research Institute, Portland, OR · Karl Lewis, University of Colorado Cancer Center, Aurora, CO · Troy Guthrie, Baptist Cancer Institute, Jacksonville · Jonathan S. Zager, Moffitt Cancer Center, Tampa, FL · Gerald P. Linette, Washington University School of Medicine, St Louis, MO · Kevin Harrington, Institute of Cancer Research, Royal Marsden Hospital, London · Mark R. Middleton, National Institute for Health Research Biomedical Research Centre, Oxford, United Kingdom · Wilson H. Miller Jr, McGill University, Montreal, Quebec, Canada · and Susan Doleman and Robert S. Coffin, Amgen, Woburn, MA. · Pubmed 26014293
  • *Northern California Melanoma Center, St. Mary's Medical Center, San Francisco †The Angeles Clinic and Research Institute, Santa Monica ‡Scott Cruickshank and Associates, Santa Barbara, CA. · Pubmed 25616203
2009
  • Northern California Melanoma Center, Saint Mary's Medical Center, San Francisco, CA 94117-1079, USA. · Pubmed 19483646
Miscellaneous institutions in Santa Barbara
2015
  • *Northern California Melanoma Center, St. Mary's Medical Center, San Francisco †The Angeles Clinic and Research Institute, Santa Monica ‡Scott Cruickshank and Associates, Santa Barbara, CA. · Pubmed 25616203
Miscellaneous institutions in Santa Monica
2015
  • *Northern California Melanoma Center, St. Mary's Medical Center, San Francisco †The Angeles Clinic and Research Institute, Santa Monica ‡Scott Cruickshank and Associates, Santa Barbara, CA. · Pubmed 25616203
Miscellaneous institutions in Miami
2009
  • Mount Sinai Comprehensive Cancer Center Melanoma Program, Miami Beach, FL 33140, USA. · Pubmed 19307996
Yearly article counts 001020000020
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.